Genentox Laboratories LLC

Genentox Laboratories LLC was paid $6.92M by Medicaid between Jul 2020 and Dec 2024, across 76 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 48% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#92 of 561

Median peer was paid$222K

This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	1,398	$48K
2021	26,832	$780K
2022	85,890	$2.93M
2023	59,732	$2.11M
2024incomplete	48,307	$1.05M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	48%	52,348	17,313	$3.29M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	12%	35,422	11,117	$828K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	9.0%	32,430	10,842	$620K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	6.8%	29,319	9,694	$467K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	4.9%	18,926	7,193	$341K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	4.1%	5,431	4,886	$285K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	2.7%	5,371	3,246	$190K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	2.2%	4,804	3,093	$153K
87481		1.7%	2,859	2,594	$114K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	1.4%	1,982	1,608	$94K
87150		1.0%	2,192	2,069	$71K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.0%	232	210	$69K

64 more codes

G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	1,566	$68K
87634		<1%	1,553	$47K
87631		<1%	1,729	$35K
87486		<1%	2,910	$34K
87581		<1%	2,684	$29K
87503		<1%	1,550	$21K
87500		<1%	2,362	$20K
87498		<1%	1,136	$20K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,584	$19K
87640		<1%	2,354	$15K
87653		<1%	2,383	$15K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,362	$15K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	256	$11K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	212	$6K
87496		<1%	105	$3K
87511		<1%	105	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	106	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	112	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	109	$3K
87563		<1%	88	$3K
80053	Comprehensive metabolic panel	<1%	818	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	948	$3K
80061	Lipid panel	<1%	631	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	207	$2K
86480		<1%	48	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	479	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	275	$1K
87641		<1%	737	$1K
80074		<1%	30	$666.27
82746		<1%	108	$619.66
86769		<1%	17	$588.98
82670		<1%	36	$367.69
86141		<1%	110	$349.66
83735		<1%	37	$341.35
82607		<1%	39	$277.46
82627		<1%	36	$276.05
84403		<1%	30	$236.66
83090		<1%	65	$224.72
84153		<1%	27	$224.22
83970		<1%	18	$188.16
83690		<1%	35	$171.07
82150		<1%	36	$161.23
84550		<1%	122	$140.57
84436		<1%	56	$125.75
84402		<1%	18	$122.28
82626		<1%	18	$121.32
82728		<1%	17	$117.24
81001		<1%	91	$105.58
84270		<1%	18	$101.10
87541		<1%	20	$99.66
84144		<1%	18	$98.82
81003		<1%	96	$92.98
82533		<1%	18	$78.24
80048	Basic metabolic panel (calcium, ionized)	<1%	23	$58.97
83002		<1%	16	$58.96
87086	Culture, bacterial; quantitative colony count, urine	<1%	12	$55.52
83615		<1%	53	$53.41
82550		<1%	51	$51.82
80076		<1%	24	$46.11
85652		<1%	39	$33.78
83540		<1%	12	$32.67
82977		<1%	16	$12.10
87899		0%	36	$0.00
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	0%	36	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, AMBREEN (OWNER)